Literature DB >> 25361018

Efficacy of pentoxifylline and tadalafil in rat model of ischemic colitis.

Enver Reyhan1, Oktay Irkorucu, Ali Surmelioglu, Selvinaz Ozkara, Kamuran Cumhur Deger, Mehmet Aziret, Hasan Erdem, Suleyman Cetinkunar, Pelin Demirturk, Ahmet Ozer Sehirli.   

Abstract

OBJECTIVE: The aim of this study is to investigate the efficacy of tadalafil against pentoxifylline in rat model of ischemic colitis (IC). MATERIAL-
METHODS: Thirty-two Wistar albino rats were subjected to laparotomy and left colon devascularization to create an IC model and then randomly placed into four groups. Group-1 (sham group) was administered 0.9% NaCl following laparotomy, group 2 (control group) was administered 0.9% NaCl following induced IC, group 3 was given pentoxifylline (n = 8), and group 4 was given tadalafil. On the third day; macroscopic findings, Gomella's ischemic area and Wallace scoring, histopathological analysis, and Chiu scoring were performed, and malondialdehyde (MDA) measurement in ischemic colon tissue was carried out through chemical analysis.
RESULTS: Significant differences were observed in acidic fluid, bowel dilatation, and serosal change (p < .05). The ischemic area measured 63.3 mm(2) in the control group, 2.8 mm(2) in the pentoxifylline group (p = .0001), and 2.4 mm(2) (p = .0001) in the tadalafil group. A significant difference was seen between the sham group and the control and pentoxifylline groups (p < .01), in terms of Wallace score and Chiu classification. Similarly, a significant difference was determined between the control group and pentoxifylline and tadalafil groups (p < .01), but no significant difference was established between the pentoxifylline group and tadalafil group (p = .33). MDA measurement was found on an average to be 63.7 in the control group, 22.7 in group 3 and 22.8 in group 4 (p = 001).
CONCLUSION: Although tadalafil is superior to pentoxifylline, both drugs are considered to have positive effects.

Entities:  

Keywords:  ischemic colitis; malondialdehyde; pentoxifylline; phosphodiesterase-5; rat; tadalafil

Mesh:

Substances:

Year:  2014        PMID: 25361018     DOI: 10.3109/08941939.2014.971204

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  3 in total

1.  Phosphodiesterase-5 inhibition suppresses colonic inflammation-induced tumorigenesis via blocking the recruitment of MDSC.

Authors:  Shiyong Lin; Jing Wang; Lihui Wang; Jing Wen; Yandong Guo; Weiguang Qiao; Jieqiong Zhou; Guoliang Xu; Fachao Zhi
Journal:  Am J Cancer Res       Date:  2017-01-01       Impact factor: 6.166

2.  Protective effects of pentoxifylline in small intestine after ischemia-reperfusion.

Authors:  Seracettin Eğin; Mehmet İlhan; Süleyman Bademler; Berk Gökçek; Semih Hot; Hakan Ekmekçi; Özlem Balcı Ekmekçi; Gamze Tanrıverdi; Fatma Kaya Dağıstanlı; Gülçin Kamalı; Sedat Kamalı; Recep Güloğlu
Journal:  J Int Med Res       Date:  2018-07-20       Impact factor: 1.671

Review 3.  Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease.

Authors:  Linshan Duan; Shuyu Cheng; Long Li; Yanling Liu; Dan Wang; Guoyan Liu
Journal:  Front Pharmacol       Date:  2021-07-14       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.